153 related articles for article (PubMed ID: 24285323)
1. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
2. Cerebral acetylcholinesterase imaging: development of the radioprobes.
Kikuchi T; Okamura T; Fukushi K; Takahashi K; Toyohara J; Okada M; Zhang MR; Irie T
Curr Top Med Chem; 2007; 7(18):1790-9. PubMed ID: 17979787
[TBL] [Abstract][Full Text] [Related]
3. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase imaging: its use in therapy evaluation and drug design.
Shinotoh H; Fukushi K; Nagatsuka S; Irie T
Curr Pharm Des; 2004; 10(13):1505-17. PubMed ID: 15134572
[TBL] [Abstract][Full Text] [Related]
5. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
7. [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders].
Shinotoh H
Rinsho Shinkeigaku; 2007 Nov; 47(11):822-5. PubMed ID: 18210807
[TBL] [Abstract][Full Text] [Related]
8. The position of fluorine in CP-118,954 affects AChE inhibition potency and PET imaging quantification for AChE expression in the rat brain.
Lee BC; Moon BS; Park HS; Jung JH; Park HS; Park DD; de Candia M; Denora N; Altomare CD; Kim SE
Eur J Pharm Sci; 2017 Nov; 109():209-216. PubMed ID: 28818531
[TBL] [Abstract][Full Text] [Related]
9. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers.
Shao X; Koeppe RA; Butch ER; Kilbourn MR; Snyder SE
Bioorg Med Chem; 2005 Feb; 13(3):869-75. PubMed ID: 15653352
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.
Bencherif B; Endres CJ; Musachio JL; Villalobos A; Hilton J; Scheffel U; Dannals RF; Williams S; Frost JJ
Synapse; 2002 Jul; 45(1):1-9. PubMed ID: 12112408
[TBL] [Abstract][Full Text] [Related]
12. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs.
Wang JQ; Miller MA; Fei X; Stone KL; Lopshire JC; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
Nucl Med Biol; 2004 Oct; 31(7):957-64. PubMed ID: 15464398
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase.
Choe YS; Oh S; Shim I; Naruto S; Chi DY; Kim SE; Lee K; Choi Y; Kim B
Nucl Med Biol; 2000 Apr; 27(3):263-7. PubMed ID: 10832083
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging.
Kimura H; Kawai T; Hamashima Y; Kawashima H; Miura K; Nakaya Y; Hirasawa M; Arimitsu K; Kajimoto T; Ohmomo Y; Ono M; Node M; Saji H
Bioorg Med Chem; 2014 Jan; 22(1):285-91. PubMed ID: 24315193
[TBL] [Abstract][Full Text] [Related]
18. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain.
Koeppe RA; Frey KA; Snyder SE; Meyer P; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1150-63. PubMed ID: 10532640
[TBL] [Abstract][Full Text] [Related]
19. Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers.
Ohya T; Okamura T; Nagai Y; Fukushi K; Irie T; Suhara T; Zhang MR; Fukumura T; Kikuchi T
Neuroimage; 2011 Jun; 56(3):1105-10. PubMed ID: 21324368
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of radioiodine-labelled CP-118,954 for the in-vivo imaging of acetylcholinesterase.
Lee I; Choe YS; Ryu EK; Choi BW; Choi JY; Choi Y; Lee KH; Kim BT
Nucl Med Commun; 2007 Jul; 28(7):561-6. PubMed ID: 17538398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
